Publication:
Subcutaneous CERA for the Treatment of Chronic Renal Anemia in Predialysis Patients

Simple item page
dc.contributor.authorUstundag, Sedat
dc.contributor.authorDOGAN, Ekrem
dc.contributor.authorDURANAY, Murat
dc.contributor.authorKazancioglu, RÜMEYZA
dc.contributor.authorCELIK, Vedat
dc.contributor.authorUNSAL, Abdulkadir
dc.contributor.authorALTINTEPE, Lutfullah
dc.contributor.authorDursun, Belda
dc.contributor.authorAKBAS, Ertugrul
dc.contributor.authorOZDENER, Fatih
dc.contributor.authorYildiz, Alaattin
dc.contributor.institutionauthorKAZANCIOĞLU, RÜMEYZA
dc.date.accessioned2019-10-05T13:17:05Z
dc.date.available2019-10-05T13:17:05Z
dc.date.issued2016-05-01
dc.description.abstractBackground: We investigated the efficacy, safety and tolerability of once-monthly administration of C.E.R.A. in erythropoiesis stimulating agents (ESAs) naive predialysis patients with CKD for anemia treatment
dc.identifier10.4149/bll_2017_066
dc.identifier.citationUstundag S., DOGAN E., DURANAY M., Kazancioglu R., CELIK V., UNSAL A., ALTINTEPE L., Dursun B., AKBAS E., OZDENER F., et al., -Subcutaneous CERA for the Treatment of Chronic Renal Anemia in Predialysis Patients-, BALKAN MEDICAL JOURNAL, cilt.33, ss.322-330, 2016
dc.identifier.doi10.5152/balkanmedj.2016.141173
dc.identifier.scopus84971612089
dc.identifier.urihttps://hdl.handle.net/20.500.12645/1826
dc.identifier.wosWOS:000379332000011
dc.language.isoen
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleSubcutaneous CERA for the Treatment of Chronic Renal Anemia in Predialysis Patients
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameBRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY
local.avesis.id2bcba88f-21fc-4d90-bb20-ee4e8eca726e
local.avesis.response1696
local.publication.isinternational1
relation.isAuthorOfPublicationeca7bd30-6b6e-444d-96ae-2961c39f2107
relation.isAuthorOfPublication.latestForDiscoveryeca7bd30-6b6e-444d-96ae-2961c39f2107
Files
Collections
Silinecekler